Clinical Trials

Colorectal Neoplasms

NCT04215731 2026-03-03

FOBEAR

Phase 3 Recruiting

582 enrolled

Rectal Neoplasms

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

30 enrolled

Advanced Biliary Tract Carcinoma

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

Phase 3 Recruiting

2,000 enrolled

Esophageal Neoplasms

NCT06468280 2026-01-21

ROSETTE

84 enrolled

Stomach Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Phase 2 Enrolling by invitation

Esophageal Squamous Cell Carcinoma

NCT07139951 2025-12-31

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence

16 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT03042169 2025-12-23

SURGIGAST

Phase 3 Terminated

6 enrolled

Stomach Neoplasms

NCT04587739 2025-12-23

KARCHER-1

Phase 1 Recruiting

30 enrolled

Phase NA Active not recruiting

Carcinoma, Hepatocellular

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

2 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT06940947 2025-11-20

ETHOS

Phase 3 Recruiting

434 enrolled

Colonic Neoplasms

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Phase 1 Terminated

4 enrolled

Pancreatic Neoplasms

NCT06994299 2025-11-18

PRISM

Phase 2 Withdrawn

Carcinoma, Hepatocellular

NCT04982653 2025-11-10

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

140 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

168 enrolled

Pancreatic Neoplasms

NCT07200141 2025-09-30

SIB-NCRT-pumch

156 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT07194616 2025-09-26

Rectal Cancer CTC Trial

120 enrolled

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT07162714 2025-09-09

STAR

30 enrolled

Rectal Neoplasms

NCT05265208 2025-08-06

SIROCHO

62 enrolled

Resectable Intrahepatic Cholangiocarcinoma

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

60 enrolled

Esophageal Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

50 enrolled

Esophageal Neoplasms, Esophagitis

NCT02366819 2025-06-13

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Recruiting

36 enrolled

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT06646445 2025-06-13

PREMICES

60 enrolled

Phase 2/3 Not yet recruiting

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT07000253 2025-06-02

OMEC-5

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06908031 2025-05-14

CRIT

49 enrolled

Phase NA Active not recruiting

Rectal Neoplasms

NCT01792934 2025-04-15

ORCHESTRA

478 enrolled

Multi-organ Metastatic Colorectal Cancer

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT04503694 2025-03-05

REGINA

72 enrolled

Rectal Neoplasms

NCT03092518 2025-02-19

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Phase 2 Completed

27 enrolled 13 charts

Adenocarcinoma, Stomach Neoplasms

NCT02972372 2025-02-10

CELAEC

196 enrolled

Esophageal Neoplasms

NCT05296005 2025-02-07

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Phase 1 Withdrawn

Clinical Stage I Gastric Cancer AJCC v8

NCT02485834 2025-01-20

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Phase 2 Terminated

5 enrolled 11 charts

Stomach Neoplasms

NCT06775652 2025-01-15

ESCC

Phase 3 Completed

254 enrolled

Esophageal Squamous Cell Carcinoma

NCT06758830 2025-01-09

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

400 enrolled

Phase NA Active not recruiting

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT06762158 2025-01-07

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

50 enrolled

Esophageal Squamous Cell Carcinoma

NCT04890171 2024-12-27

ERASE-GC

708 enrolled

Stomach Neoplasms

NCT06751394 2024-12-27

TRACER

44 enrolled

Rectal Neoplasms

NCT05546411 2024-12-17

A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer

Phase 2 Terminated

8 enrolled 11 charts

Pancreatic Neoplasms

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

70 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT02578368 2024-11-12

FLOT5

Phase 3 Completed

183 enrolled

Stomach Neoplasms

NCT05964530 2024-09-20

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

180 enrolled

Rectal Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Phase NA Not yet recruiting

Rectal Neoplasms

NCT06603974 2024-09-19

EASOBFGE

48 enrolled

Stomach Neoplasms

NCT00297791 2024-08-21

COLORII

Phase 3 Completed

1,044 enrolled

Phase 3 Active not recruiting

Rectal Neoplasms

NCT03879109 2024-08-14

GRECCAR15

58 enrolled

Rectal Neoplasms

NCT04231526 2024-07-31

Pembrolizumab in Early Stage Colon Cancer

Phase 2 Withdrawn

Colonic Neoplasms

NCT06387810 2024-07-10

undetermined

45 enrolled